AzTrials
AzTrials

Autism Spectrum DisorderNCT07532395

FMS-CrossFit Training Program (FCTP) to Improve School Readiness in Preschool Children With Autism Spectrum Disorder

A study testing FCTP program in people with Autism Spectrum Disorder, run by Peking University at 2 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Autism spectrum disorder (ASD) is an increasing public health concern, with preschool children often exhibiting persistent deficits in school readiness. However, targeted and developmentally comprehensive interventions remain limited. Read more about this study

Who is it for?
Ages 3 to 6 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
FCTP program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
184 participants
Where
2 sitesChina
Study dates
22 Nov 2025to 24 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • age 3-6 years;
  • confirmed ASD diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria or the Autism Diagnostic Observation Schedule-Second Edition (ADOS-2);
  • written informed consent from parent/caregiver.

Who cannot join

  • participation in structured exercise programs within the preceding 6 months;
  • comorbid severe neurological disorders (e.g., epilepsy, phenylketonuria, fragile X syndrome, tuberous sclerosis) or major psychiatric conditions (e.g., schizophrenia, bipolar disorder);
  • visual, auditory or intellectual impairments that would interfere with participation;
  • history of significant head trauma or brain injury;
  • medical contraindications to physical activity ;
  • other factors deemed unsuitable for program participation by the research team.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

China2 sites, 2 recruiting
  • Pku Care Brain Health

    Beijing, Beijing Municipality, 100088

    Yawen Zhou, +86 13269477857, bd-jiangchundi936@pkucare.com

    Not yet recruiting
  • Fujian Provincial Maternity and Children's Hospital

    Fuzhou, Fujian, 350001

    Yanzheng Pan, PhD candidate, (+86)13161439008, panyanzheng@stu.pku.edu.cn

    Xinxin Huang, master

    Recruiting

Other trials in China

About this study

Official title: A Randomized Controlled Trial of the FMS-CrossFit Training Program (FCTP) to Improve School Readiness in Preschool Children With Autism Spectrum Disorder

Autism spectrum disorder (ASD) is an increasing public health concern, with preschool children often exhibiting persistent deficits in school readiness. However, targeted and developmentally comprehensive interventions remain limited. This randomized controlled trial will evaluate a 12-week Fundamental Movement Skills-CrossFit Training Program (FCTP) in 184 children with ASD aged 3-6 years, compared with a Treatment As Usual (TAU) control group. The program integrates progressive FMS training with CrossFit-style circuit training to improve motor competence, social interaction, and self-regulation. Primary outcomes focus on school readiness assessed by the Strengths and Difficulties Questionnaire (SDQ), while secondary outcomes include motor development, executive function, social responsiveness, and biomarkers. Assessments will be conducted at baseline, mid-intervention (8 weeks), post-intervention (12 weeks), and follow-up (20 weeks).

Read the detailed description

Autism spectrum disorder (ASD) is a major public health concern, and increasing prevalence underscores the need for evidence-based interventions that improve functional outcomes. While school readiness is a critical developmental milestone, deficits remain pervasive among preschoolers with ASD, yet targeted interventions remain scarce. Exercise interventions grounded in Fundamental Movement Skills (FMS) are promising, but many existing approaches lack systematic progression and do not adequately address the multidimensional nature of school readiness.

This randomized controlled trial will evaluate the effectiveness of a novel Fundamental Movement Skills-CrossFit Training Program (FCTP) in 184 preschool children with ASD aged 3-6 years. Participants will be randomly assigned to the FCTP intervention group or a Treatment As Usual (TAU) control group using a computer-generated randomization. The FCTP is a 12-week structured program integrating FMS development through CrossFit-style circuit training, designed to enhance motor competence, social interaction, and self-regulation skills essential for school readiness. Primary outcomes will include school readiness measures assessed using the Strengths and Difficulties Questionnaire (SDQ). Secondary outcomes will encompass motor development, executive function, social responsiveness, and biomarker analyses. Assessments will be conducted at baseline, 8 weeks (mid-intervention), 12 weeks (end-of-intervention), and 20 weeks (8 weeks post-intervention).

Discussion: This study will address a critical gap in early intervention research by targeting school readiness through a systematic, theory-driven approach combining motor skill development with social learning opportunities. The FCTP will offer several advantages over traditional interventions: systematic FMS progression, group-based social interaction, cost-effectiveness, and high implementation feasibility. By integrating neuroplasticity principles with contextual learning, this intervention will provide a comprehensive approach to preparing children with ASD for successful educational transitions.

Being tested
FCTP program, treatment as usual (TAU) (Control Group)
Keywords
Autism Spectrum Disorder, CrossFit
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FCTP programBehavioural

    Also called Fundamental Movement Skills-CrossFit Training Program

    Each session consists of three parts: warm up (5 minutes), basic motor skills training (25 minutes) and cool-down with stretching (5 minutes). The program combines physical, social, linguistic and communication skills training aspects, and can be divided into three phases (about 2 to 4 weeks for each phase) to achieve different targets.

    Stage 1: Basic Motor Skills Learning Stages:

    This stage primarily focuses on low-intensity activities over a period of 1 to 3 weeks.

    Stage 2: Basic Motor Skills Proficiency Stage:

    This stage is characterized by low to moderate intensity and typically lasts for 4 to 7 weeks.

    Stage 3: Basic Motor Skills Enhancement stage:

    This stage is conducted at a moderate intensity and focuses on the intensive development of motor skills over a period from 8 to 12 weeks.

  • treatment as usual (TAU) (Control Group)Behavioural

    Also called Treatment As Usual

    The control group receives treatment as usual (TAU), allowing participants to engage in routine services of their choice, including sensory integration therapy, social skills training, language intervention, Transcranial Magnetic Stimulation (TMS), etc.

Study groups in NCT07532395
Study groupRoleWhat they receive
FCTP intervention groupExperimentalParticipants in the FCTP intervention group will receive two supervised sessions per week of the novel Fundamental Movement Skills-CrossFit Training Program (FCTP), in place of traditional sensory integration therapy.
Receives: Behavioral: FCTP program
control groupActive comparatorThe control group receives treatment as usual (TAU), allowing participants to engage in routine services of their choice, including sensory integration therapy, social skills training, language intervention, transcranial magnetic stimulation (TMS), etc.
Receives: Behavioral: treatment as usual (TAU) (Control Group)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. School readiness

    The Strengths and Difficulties Questionnaire (SDQ) was used to assess school readiness. The Total Difficulties Score ranges from 0 to 40, with higher scores indicating more severe difficulties in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks), follow-up (20 weeks)

  2. Gross Motor Development

    The Test of Gross Motor Development - 3rd edition (TGMD-3) is a measure of fundamental motor skills.

    Measured: baseline, post-intervention (12 weeks)

Secondary outcomes (8)
  1. Severity of autism

    The Autism Behavior Checklist (ABC) is a widely used screening instrument comprising 57 items that characterize behavioral features of children with autism. The scores range from 0 to 228, with higher scores indicating greater symptom severity in the child.

    Measured: baseline, post-intervetion (12 weeks)

  2. Social responsiveness

    The social responsiveness scale-2 (SRS-2) is a 65-item parent-reported questionnaire designed to measure the severity of autism symptoms as a quantitative trait. The scores range from 0 to 195, with higher scores indicating more severe problems in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks)

  3. Executive function

    The Behavior Rating Inventory of Executive Function (BRIEF) is an 86-item in five subscales screening for executive function impairment in ages 5-18 years. The Behavior Rating Inventory of Executive Function-Preschool Version (BRIEF-P) is a validated tool for assessing executive function in children aged 2-5 based on daily behaviors. The scores range from 0 to 189, with higher scores indicating greater symptom severity in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks), follow-up (20 weeeks)

  4. Neuropsychological assessment

    The Early Years Toolbox (EYT) is a low-cost iPad software to assess young children's expressive language, executive function, and social development.

    Measured: baseline, post-intervention (12 weeks)

  5. Caregiver burden

    Zarit Caregiver Burden Interview is a widely used tool for measuring caregiver burden. The scores range from 0 to 16, with higher scores indicating greater burden.

    Measured: baseline, 8 weeks post-baseline, post intervention(12 weeks), follow up(20 weeks)

  6. Sleeping conditions

    The Children's Sleep Habits Questionnaire (CSHQ) comprises eight subscales that assess different aspects of sleep behaviors. The scores range from 0 to 99, with higher scores indicating greater symptom severity in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks)

  7. Appetite status

    The initiative eating subscale of the Chinese Preschoolers' Eating Behavior Questionnaire (CPEBQ-IE) has 7 questions that assess the active eating behaviors of preschool children. The scores range from 0 to 20, with lower scores indicating greater symptom severity in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks)

  8. Gastrointestinal issues

    The 6-item Gastrointestinal Severity Index (6-GSI) is employed for evaluating gastrointestinal symptoms. The scores range from 0 to 12, with higher scores indicating greater symptom severity in the child.

    Measured: baseline, 8 weeks post-baseline, post-intervention (12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study start22 Nov 2025
  3. Primary completion24 Nov 2026 (estimated)
  4. Study completion24 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
184 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07532395
Sponsor's protocol ID
IRB00001052-25110-A01
Status last verified
Feb 2026
First submitted
8 Apr 2026
Last updated
20 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared due to participant privacy and confidentiality protections. The informed consent did not include provisions for data sharing beyond the research team, and relevant data protection regulations preclude dissemination of identifiable personal health information.

Publications

  • Zhang L, Zhang C, Yuan X, Ji Y. The impact of exercise interventions on core symptoms of 3-12-year-old children with autism spectrum disorder: a systematic review and network meta-analysis. Eur Child Adolesc Psychiatry. 2025 Jul;34(7):1991-2005. doi: 10.1007/s00787-025-02696-8. Epub 2025 Mar 25.

    PubMed 40131458

Questions about this trial

What is this clinical trial studying?

A study testing FCTP program in people with Autism Spectrum Disorder, run by Peking University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yuelong Ji, PHD ((+86)13161989008, yuelong.ji@pku.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

School readiness (time frame: baseline, 8 weeks post-baseline, post-intervention (12 weeks), follow-up (20 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07532395, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in